科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

研究此手术的领域

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 未找到姓氏以该字母开头的医生 A
  2. 未找到姓氏以该字母开头的医生 B
  3. 主动 查找姓氏以该字母开头的医生 C
  4. 未找到姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 未找到姓氏以该字母开头的医生 G
  8. 未找到姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 查找姓氏以该字母开头的医生 K
  12. 查找姓氏以该字母开头的医生 L
  13. 查找姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 未找到姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 未找到姓氏以该字母开头的医生 S
  20. 未找到姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: C

  1. Paul E. Croarkin, D.O., M.S.

    Paul E. Croarkin, D.O., M.S.

    1. Psychiatrist
    1. Rochester, MN
    擅长领域:

    Transcranial magnetic stimulation, Teen depression, Mood disorder, Childhood-onset disorder

研究

妙佑医疗国际的精神病学和心理学科室在继续研究 rTMS 在青少年难治性抑郁症方面的应用。

详细了解妙佑医疗国际的精神病学和心理学研究

文献

请参阅妙佑美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在 rTMS 领域的文献著述列表。

Research Profiles

查看所有医生 • Florida

April 07, 2023
  1. Brain stimulation therapies. National Institute of Mental Health. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies.shtml#part_152879. Accessed Jan 18, 2023.
  2. McClintock SM, et al. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. The Journal of Clinical Psychology. 2018; doi:10.4088/JCP.16cs10905.
  3. Trangle M, et al. Depression, adult in primary care. Institute for Clinical Systems Improvement.
  4. https://www.icsi.org/guidelines__more/catalog_guidelines_and_more/catalog_guidelines/catalog_behavioral_health_guidelines/depression/. Accessed Jan. 18, 2023.
  5. AskMayoExpert. Transcranial magnetic stimulation. Mayo Clinic; 2023.
  6. Holtzheimer PE. Unipolar depression in adults: Indications, efficacy, and safety of transcranial magnetic stimulation (TMS). https://www.uptodate.com/contents/search. Accessed Jan. 18, 2023.
  7. Holtzheimer PE. Unipolar major depression: Administering transcranial magnetic stimulation (TMS). https://www.uptodate.com/contents/search. Accessed Jan. 18, 2023.
  8. ECT, TMS and other brain stimulation therapies. National Alliance on Mental Illness. https://www.nami.org/Learn-More/Treatment/ECT,-TMS-and-Other-Brain-Stimulation-Therapies. Accessed Jan. 18, 2023.
  9. Garnaat SL, et al. Updates on transcranial magnetic stimulation for major depressive disorder. Psychiatric Clinics of North America. 2018; doi:10.1016/j.psc.2018.04.006.
  10. Sebastian R, et al. Clinical implementation of noninvasive brain stimulation in an outpatient neurorehabilitation program. American Journal of Physical Medicine & Rehabilitation. 2023; doi:10.1097/PHM.0000000000002135.
  11. Kung S (expert opinion). Mayo Clinic. Jan. 30, 2023.
  12. Mahoney III JJ, et al. Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment. Journal of the Neurological Sciences. 2020; doi: 10.1016/j.jns.2020.117149.
  13. News release. Aug. 17, 2018. U.S. Food and Drug Administration; 2018. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-transcranial-magnetic-stimulation-treatment-obsessive-compulsive-disorder. Accessed Jan. 19, 2023.
  14. Cohen SL, et al. A visual and narrative timeline of U.S. FDA milestones for transcranial magnetic stimulation (TMS) devices. Brain Stimulation. 2022; doi:10.1016/j.brs.2021.11.010.